News
Demis Hassabis, CEO of Google DeepMind, offered details about the future of Gemini AI, AGIs, and self-aware systems.
Hassabis pointed out the potential of AI to transform medicine by significantly lessening the time and expense of drug development.
Modern Engineering Marvels on MSN11h
Accelerating the Race to Human-Like AGI Raises Alarming Questions About Safety and Ethical OversightArtificial general intelligence could be here within the coming years,” writes Shane Legg, Co-Founder and Chief AGI Scientist ...
21h
ABP News on MSNAI’s Health Revolution: DeepMind CEO Envisions End Of All Disease Within A DecadeHassabis also spoke to Reid Hoffman, co-founder of LinkedIn, about the scale and speed at which AI is transforming science. Using DeepMind’s AlphaFold technology, researchers managed to predict the ...
Google DeepMind CEO Demis Hassabis pointed out that designing a new drug usually takes several years but with the help of AI, ...
At a TED Talk, Google revealed innovative AI glasses that can remember scenes for up to 10 minutes and interact with users in ...
Emotional bonds with AI are no longer speculative—they’re shaping user behavior and redefining the risks legal professionals ...
Nobel laureate and DeepMind CEO Demis Hassabis envisions a future where AI revolutionizes healthcare by drastically ...
Then all the caution abruptly ended. The Trump administration and Congressional GOP embraced the go-go attitude of ...
This is exactly what Demis Hassabis, CEO of Google DeepMind, is talking about. In a recent interview on CBS' 60 Minutes, Hassabis shared a bold idea — artificial intelligence could help us wipe out ...
Experts have been surpassed by AI in virology lab troubleshooting according to the VCT study, leading to dual-use warnings and responses from AI labs like OpenAI.
The core problem is what AI developers call “misalignment”. When the goals for which a model was designed and trained clash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results